Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology
Frédéric Jaisser, Nicolette Farman, Rhian M. Touyz
Pharmacological Reviews (2015) Vol. 68, Iss. 1, pp. 49-75
Open Access | Times Cited: 289

Showing 26-50 of 289 citing articles:

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Luís M. Ruilope, Rajiv Agarwal, Stefan D. Anker, et al.
Hypertension (2022) Vol. 79, Iss. 12, pp. 2685-2695
Open Access | Times Cited: 52
Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
Dong‐Lim Kim, Seung‐Eun Lee, Nan Hee Kim
Endocrinology and Metabolism (2023) Vol. 38, Iss. 1, pp. 43-55
Open Access | Times Cited: 27
Cardiovascular-renal protective effect and molecular mechanism of finerenone in type 2 diabetic mellitus
Ruolin Lv, Lili Xu, Lin Che, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 25
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives
Bertram Pitt, João Pedro Ferreira, Faı̈ez Zannad
European Heart Journal - Cardiovascular Pharmacotherapy (2016) Vol. 3, Iss. 1, pp. 48-57
Open Access | Times Cited: 81
Adipocytes, aldosterone and obesity-related hypertension
Aurélie Nguyen Dinh Cat, Malou Friederich‐Persson, Anna White, et al.
Journal of Molecular Endocrinology (2016) Vol. 57, Iss. 1, pp. F7-F21
Open Access | Times Cited: 67
Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
Stefania Gorini, Seung Kyum Kim, Marco Infante, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 66
New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure
Irene Capelli, Lorenzo Gasperoni, Marco Ruggeri, et al.
Journal of Nephrology (2019) Vol. 33, Iss. 1, pp. 37-48
Closed Access | Times Cited: 63
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Min Zhao, Irmela Mantel, Emmanuelle Gelizé, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function
Ruihan Tang, Nandini Acharya, Ayshwarya Subramanian, et al.
Science Immunology (2022) Vol. 7, Iss. 69
Open Access | Times Cited: 36
The Effect of Aldosterone on Cardiorenal and Metabolic Systems
Hiromasa Otsuka, Masanori Abe, Hiroki Kobayashi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5370-5370
Open Access | Times Cited: 21
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
Christian W. Mende, Rohan Samarakoon, Paul J. Higgins
American Journal of Nephrology (2023) Vol. 54, Iss. 1-2, pp. 50-61
Open Access | Times Cited: 17
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review
Wei‐Ting Wang, Tsung-Hui Wu, Leay‐Kiaw Er, et al.
Hypertension Research (2024) Vol. 47, Iss. 5, pp. 1103-1119
Closed Access | Times Cited: 6
Brain mineralocorticoid receptor function in control of salt balance and stress-adaptation
E. R. de Kloet, Marian Joëls
Physiology & Behavior (2017) Vol. 178, pp. 13-20
Open Access | Times Cited: 59
Evolution of human, chicken, alligator, frog, and zebrafish mineralocorticoid receptors: Allosteric influence on steroid specificity
Yoshinao Katsu, Kaori Oka, Michael E. Baker
Science Signaling (2018) Vol. 11, Iss. 537
Open Access | Times Cited: 58
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
Alessandro Cannavò, Leonardo Bencivenga, Daniela Liccardo, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 58
Integrative approach using liver and duodenum RNA-Seq data identifies candidate genes and pathways associated with feed efficiency in pigs
Yuliaxis Ramayo‐Caldas, María Ballester, Juan Pablo Sánchez, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology
Lisa M. Sevilla, Paloma Pérez
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1906-1906
Open Access | Times Cited: 57
Cutaneous Wound Healing in Diabetic Mice Is Improved by Topical Mineralocorticoid Receptor Blockade
Van Tuan Nguyen, Nicolette Farman, Roberto Palacios, et al.
Journal of Investigative Dermatology (2019) Vol. 140, Iss. 1, pp. 223-234.e7
Open Access | Times Cited: 50
Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation
Judit Bigas, Lisa M. Sevilla, Elena Carceller, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 6
Open Access | Times Cited: 49
Global transcriptomic analysis suggests carbon dioxide as an environmental stressor in spaceflight: A systems biology GeneLab case study
Afshin Beheshti, Egle Cekanaviciute, David J. Smith, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 49
Progesterone: An enigmatic ligand for the mineralocorticoid receptor
Michael E. Baker, Yoshinao Katsu
Biochemical Pharmacology (2020) Vol. 177, pp. 113976-113976
Open Access | Times Cited: 49
Role of Aldosterone in Renal Fibrosis
Aanchal Shrestha, Ruochen Che, Aihua Zhang
Advances in experimental medicine and biology (2019), pp. 325-346
Closed Access | Times Cited: 46
Transcriptional activation of elephant shark mineralocorticoid receptor by corticosteroids, progesterone, and spironolactone
Yoshinao Katsu, Satomi Kohno, Kaori Oka, et al.
Science Signaling (2019) Vol. 12, Iss. 584
Open Access | Times Cited: 45
Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study
Hiroshi Itoh, Sadayoshi Ito, Hiromi Rakugi, et al.
Hypertension Research (2019) Vol. 42, Iss. 10, pp. 1572-1581
Open Access | Times Cited: 45
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk
Jeffrey W. Stephens, Karen Brown, Thinzar Min
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. S1, pp. 32-45
Open Access | Times Cited: 42

Scroll to top